Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,127Revenue (TTM) $M546Net Margin (%)11.6Altman Z-Score3.5
Enterprise Value $M1,041EPS (TTM) $1.3Operating Margin %17.9Piotroski F-Score8
P/E(ttm)20.8Beneish M-Score-3.0Pre-tax Margin (%)16.9Higher ROA y-yY
Price/Book1.710-y EBITDA Growth Rate %5.0Quick Ratio4.2Cash flow > EarningsY
Price/Sales2.45-y EBITDA Growth Rate %8.2Current Ratio5.1Lower Leverage y-yY
Price/Free Cash Flow17.9y-y EBITDA Growth Rate %30.0ROA % (ttm)6.3Higher Current Ratio y-yY
Dividend Yield %--PEG2.6ROE % (ttm)10.0Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M40.5ROIC % (ttm)11.5Gross Margin Increase y-yN

Gurus Latest Trades with EBS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EBSJoel Greenblatt 2016-06-30 Add0.01%$25.73 - $41.76
($36.98)
$ 27.25-26%Add 4.86%465,311
EBSKen Fisher 2016-06-30 Add$25.73 - $41.76
($36.98)
$ 27.25-26%Add 2.19%467,770
EBSJoel Greenblatt 2016-03-31 Reduce$29.88 - $37.78
($33.43)
$ 27.25-18%Reduce -0.70%443,728
EBSJoel Greenblatt 2015-12-31 Buy 0.19%$26.76 - $38.04
($33.14)
$ 27.25-18%New holding446,867
EBSKen Fisher 2015-12-31 Reduce$26.76 - $38.04
($33.02)
$ 27.25-17%Reduce -0.19%457,742
EBSKen Fisher 2015-09-30 Reduce$26.9 - $33.64
($31.15)
$ 27.25-13%Reduce -0.82%458,634
EBSKen Fisher 2015-06-30 Reduce$27.16 - $31.81
($29.24)
$ 27.25-7%Reduce -7.78%462,428
EBSJoel Greenblatt 2014-09-30 Sold Out -0.06%$20.12 - $23.51
($21.65)
$ 27.2526%Sold Out0
EBSJoel Greenblatt 2014-03-31 Buy 0.1%$21.58 - $26.53
($23.79)
$ 27.2515%New holding258,760
EBSJohn Rogers 2014-03-31 Sold Out -0.04%$21.58 - $26.53
($23.79)
$ 27.2515%Sold Out0
EBSJohn Rogers 2013-12-31 Add0.02%$16.72 - $22.62
($19.68)
$ 27.2538%Add 105.79%122,650
EBSJohn Rogers 2013-09-30 Add0.01%$14.37 - $18.35
($16.88)
$ 27.2561%Add 116.73%59,600
EBSJohn Rogers 2013-06-30 Buy 0.01%$12.35 - $14.85
($13.67)
$ 27.2599%New holding27,500
EBSJoel Greenblatt 2013-03-31 Sold Out -0.14%$13.17 - $15.96
($14.8)
$ 27.2584%Sold Out0
EBSJoel Greenblatt 2012-12-31 Buy 0.14%$12.19 - $15.19
($13.82)
$ 27.2597%New holding147,099
EBSKen Fisher 2012-12-31 Add$12.19 - $15.19
($13.82)
$ 27.2597%Add 21.09%401,700
EBSJoel Greenblatt 2011-12-31 Sold Out -0.08%$14.57 - $18.55
($16.44)
$ 27.2566%Sold Out0
EBSJoel Greenblatt 2011-06-30 Reduce-0.05%$19.51 - $23.59
($21.91)
$ 27.2524%Reduce -20.74%26,620
EBSKen Fisher 2011-06-30 Add0.01%$19.51 - $23.59
($21.91)
$ 27.2524%Add 160.57%300,305
EBSJoel Greenblatt 2011-03-31 Add0.17%$19.49 - $23.18
($21.36)
$ 27.2528%Add 243.58%33,585
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EBS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


EBS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
JOULWAN GEORGE ADirector 2016-06-06Sell4,700$44.12-36.88view
Abdun-Nabi DanielPresident & CEO 2016-06-01Sell8,699$43.74-36.33view
El-Hibri FuadChairman, 10% Owner 2016-05-27Sell9,835$43.5-35.98view
El-Hibri FuadChairman, 10% Owner 2016-05-26Sell39,759$43.13-35.43view
El-Hibri FuadChairman, 10% Owner 2016-05-25Sell85,000$42.52-34.5view
Harsanyi ZsoltDirector 2016-05-25Sell27,867$42.33-34.21view
Abdun-Nabi DanielPresident & CEO 2016-05-20Sell8,701$42-33.69view
Hauer Jerome MDirector 2016-05-19Sell3,134$41.22-32.44view
SULLIVAN LOUIS WDirector 2016-05-13Sell47,631$39.21-28.97view
El-Hibri FuadChairman, 10% Owner 2016-05-12Sell25,000$38.71-28.05view

Press Releases about EBS :

Quarterly/Annual Reports about EBS:

News about EBS:

Articles On GuruFocus.com
Weekly CEO Sales Highlight: Realpage, Anadigics, Emergent BioSolutions, ScanSource Jan 03 2016 
Emergent BioSolutions Inc. Reports Operating Results (10-Q) Nov 05 2010 
Emergent BioSolutions Inc. Reports Operating Results (10-Q) Aug 06 2010 
Emergent BioSolutions Inc. (EBS) President & COO Daniel Abdun-nabi sells 18,150 Shares Jul 30 2010 
Weekly CEO Sells Highlight: Yum! Brands Inc, Marchex Inc, iGate Corp, and Emergent BioSolutions Inc. Jul 25 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 18,800 Shares Jul 23 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 130,100 Shares Jul 22 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 84,433 Shares Jul 19 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 52,000 Shares May 14 2010 
Emergent BioSolutions Inc. Reports Operating Results (10-Q) May 06 2010 

More From Other Websites
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Emergent Biosolutions Inc. of... Aug 26 2016
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent... Aug 23 2016
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... Aug 23 2016
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent... Aug 22 2016
EBS INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class... Aug 22 2016
Brower Piven Alerts Shareholders of Upcoming Deadline in Class Action Lawsuit and Encourages Those... Aug 21 2016
EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent... Aug 20 2016
EMERGENT SHAREHOLDER ALERT By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds... Aug 19 2016
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent... Aug 17 2016
EBS INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class... Aug 17 2016
INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent... Aug 16 2016
EMERGENT BIOSOLUTIONS INC. Financials Aug 16 2016
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... Aug 16 2016
SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent... Aug 15 2016
Emergent BioSolutions Receives FDA Approval for Large-Scale Manufacturing of BioThrax in Building 55 Aug 15 2016
Emergent BioSolutions Receives FDA Approval for Large-Scale Manufacturing of BioThrax in Building 55 Aug 15 2016
SHAREHOLDER ALERT: Holzer & Holzer Files Securities Class Action Lawsuit Against Emergent... Aug 15 2016
Emergent BioSolutions Announces Conversion Rate Adjustment to 2.875% Convertible Senior Notes Due... Aug 12 2016
Emergent BioSolutions Announces Conversion Rate Adjustment to 2.875% Convertible Senior Notes Due... Aug 12 2016
IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against... Aug 12 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)